(1) Institute for Molecular Cardiovascular Research, Medical Faculty, RWTH Aachen University, Aachen, Germany; (2) Department of Cardiology, Medical Faculty, RWTH Aachen University, Aachen, Germany; (3) UMR-S 608 Inserm, Laboratoire d'hématologie et d'immunologie, UFR de pharmacie, Université de la Méditerranée, Marseille, France

(1) Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland

(1) Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

(1) Cardiovascular Division, King’s College London BHF Centre, London, UK

(1) INSERM U.770 and Univ. Paris-Sud, 94276, Le Kremlin-Bicêtre, France; (2) Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands

(1) Laboratoire de Physiopathologie de l'Endothélium - UMR_S 608 INSERM, Université de la Mediterranée, Marseille, France; (2) Laboratoire d’Hématologie, Hôpital de La Conception, Assistance publique – hôpitaux de Marseille, Marseille, France; (3) Laboratoire de Culture et Thérapie Cellulaire, INSERM CIC-BT 510, Hôpital de la Conception, Assistance publique –hôpitaux de Marseille, Marseille, France; (4) Centre de néphrologie et de transplantation rénale, hôpital de la Conception, Assistance publique – Hôpitaux de Marseille, Marseille, France

(1) Nephrology, University of Washington, Seattle, Washington, USA; (2) Bioengineering, University of Washington, Seattle, Washington, USA

(1) University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

(1) Laboratório Especial de Toxinologia Aplicada/CAT-CEPID, Instituto Butantan, São Paulo, Brazil; (2) Department of Microbiology, University of Virginia, Charlottesville, Virginia, USA

(1) Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; (2) Department of Internal Medicine and Chest Diseases and EA 3878, Brest University Hospital, Brest, France; (3) Division of Hematology, Department of Medicine, University of Western Ontario, London, Ontario, Canada; (4) Clinical Epidemiology Unit, Ottawa Health Research Institute, The Ottawa Hospital, Ottawa, Ottawa, Ontario, Canada; (5) Department of Medicine, McGill University, Montreal, Canada; (6) Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Canada; (7) Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; (8) Department of Medicine, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Canada; (9) Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; (10) Department of Internal Medicine, Geneva University Hospital, Geneva, Switzerland; (11) Department of Medicine, UC Davis School of Medicine, Sacramento, California, USA; (12) Department of Medicine, St. Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada

(1) Pharmacology Research Laboratories, Takeda Pharmaceutical Company Ltd., Osaka, Japan; (2) Takeda Global Research & Development Center Inc., Deerfield, Illinois, USA

(1) Hématologie biologique, Pôle laboratoires, CHU Nancy, Vandœuvre-lès-Nancy, France; (2) EA3452, Faculté de Pharmacie, Nancy Université, France; (3) Inserm U961, Nancy, France

(1) Institute of Chemical Technologies and Analytics, Vienna University of Technology, Vienna, Austria; (2) Baxter Innovations, Vienna, Austria

(1) Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; (2) Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA; (3) Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA; (4) Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA

(1) Department of Anatomy and Neurobiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China; (2) Department of Pathology and Laboratory Medicine, Guangdong Academy of Medical Sciences & Guangdong General Hospital, Guangzhou, China; (3) Department of Biochemistry, Zhongshan School of Medicine, SunYat-sen University, Guangzhou, China

(1) Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; (2) Department of Molecular Biology, Swedish University of Agricultural Sciences, Uppsala, Sweden; (3) Present address: MAX-lab, Lund University, Lund, Sweden and Institute of Medicinal Chemistry, University of Copenhagen, Copenhagen, Denmark; (4) Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden

(1) Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland; (2) Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; (3) Clinical Trials Unit of the Inselspital, Bern University Hospital, and the Faculty of Medicine of the University of Bern, Bern, Switzerland; (4) Department of Clinical Research, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland

(1) Department of Clinical Pharmacology, Medical University of Vienna, Austria; (2) Department of Blood Group Serology & Transfusion Medicine, Medical University of Vienna, Austria; (3) Archemix Corporation, Cambridge, Massachusetts, USA; (4) Department of Internal Medicine I, Division of Haematology, Medical University of Vienna, Austria

(1) IVS, Hôpital Lariboisière, Paris, France; (2) Haematology Laboratory, Hôpital Lariboisière, Paris, France; (3) Sanofi-Aventis Recherche, Chilly-Mazarin, France

(1) Cardiovascular Research Group, Department of Medical Biology, University of Tromsø, Tromsø, Norway; (2) Department of Clinical Medicine, University of Tromsø, Tromsø, Norway; (3) Department of Cardiothoracic and Vascular Surgery, University Hospital of North Norway, Tromsø, Norway; (4) Department of Medical Biology, University of Tromsø, Tromsø, Norway